Pliant Therapeutics (PLRX) EBT Margin (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly EBT Margin of 19579.44% for Q2 2023, down 1897509.0% year-over-year from N/an in Q2 2022, and down 524.23% quarter-over-quarter from 3136.56% in Q1 2023.
Pliant Therapeutics (PLRX) EBT Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported EBT Margin for 4 consecutive years, with 19579.44% the latest figure, recorded in Q2 2023.
- In Q2 2023, EBT Margin fell 1897509.0% year-over-year to 19579.44%; the TTM figure through Mar 2024 stood at 85820.16% (down 8437486.0% YoY), while the FY2023 annual figure was 21252.09%, down 1882936.0% from the prior year.
- EBT Margin retreated to 19579.44% in Q2 2023 per PLRX's latest filing, from 3136.56% in the prior quarter.
- Across five years, EBT Margin topped out at 6.5% in Q1 2020 and bottomed at 19579.44% in Q2 2023.
- Historically, EBT Margin has averaged 2593.54% across 4 years, with a median of 1232.85% in 2021.
- Annual changes were most pronounced in 2022 — EBT Margin jumped 68777 bps — and 2023, when it slumped 1897509 bps.
- Pliant Therapeutics' EBT Margin stood at 433.03% in 2020, then plunged by 171 bps to 1173.59% in 2021, then slumped by 55 bps to 1822.09% in 2022, then tumbled by 975 bps to 19579.44% in 2023.
- Business Quant data shows PLRX's EBT Margin at 19579.44% in Q2 2023, 3136.56% in Q1 2023, and 1822.09% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -19,579.44% |
| Mar 31, 2023 | -3,136.56% |
| Dec 31, 2022 | -1,822.09% |
| Sep 30, 2022 | -2,256.61% |
| Jun 30, 2022 | -604.35% |
| Mar 31, 2022 | -2,366.69% |
| Dec 31, 2021 | -1,173.59% |
| Sep 30, 2021 | -1,686.02% |
| Jun 30, 2021 | -1,292.12% |
| Mar 31, 2021 | -1,081.19% |
| Dec 31, 2020 | -433.03% |
| Sep 30, 2020 | -347.92% |
| Jun 30, 2020 | -536.44% |
| Mar 31, 2020 | 6.50% |